Oral folate enhances endothelial function in hyperhomocysteinaemic subjects

European Journal of Clinical Investigation

Volumn 29, Issue 8, 1999, Pages 659-662

  Bellamy, M F ^a   McDowell, I F W ^a   Ramsey, M W ^a   Brownlee, M ^a   Newcombe, R G ^a   Lewis, M J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Endothelium; Folic acid; Homocysteine; Nitric oxide; Vasodilation

Indexed keywords

FOLIC ACID; GLYCERYL TRINITRATE; HOMOCYSTEINE;

ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; HYPERHOMOCYSTEINEMIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; VITAMIN SUPPLEMENTATION;

EID: 0032783131     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00527.x     Document Type: Article

References (13)

1. 1 Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc, 1995; 274: 1049-57.
2. 2 Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet, 1991; 48: 536-45.
3. 3 Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 1995; 10: 111-3.
4. 4 Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr, 1993; 57: 47-53.
5. 5 Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ, 1998; 316: 894-8.
6. 6 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993; 362: 801-9.
7. 7 Bellamy MF, McDowell IFW. Putative mechanisms for vascular damage by homocystene. J Inher Metab Dis, 1997; 20: 307-15.
8. 8 Bellamy MF, McDowell IFW, Ramsey MW et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation, 1998; 98: 1848-52.
9. 9 Ramsey MW, Goodfellow J, Jones CJH, Luddington LA, Lewis MJ, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation, 1995; 92: 3212-9.
10. 10 Kuo AK, Still R, Cale S, McDowell IFW. Standardisation (external and internal) of HPLC assay for plasma homocysteine. Clin Chem, 1997; 43: 1653-5.
11. 11 Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol, 1998; 8: 7-20.
12. 12 Joannides R, Haefeli WE, Linder L et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation, 1995; 91: 1314-9.
13. 13 Anderson TJ, Uehata A, Gerhard MD et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol, 1995; 26: 1235-41.